1. Gatti G, Cardu G, Lusa AM, Pugliese P: Predictors of postoperative complications in “high risk” octogenarians undergoing cardiac operations. Ann Thorac Surg74:671-677, 2002.
2.
2. Lopaschuk GD: Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism. Am J Cardiol82:14k-17k, 1998.
3.
3. Lopaschuk GD, Stanley WC: Glucose metabolism in the ischemic heart: Am J Cardiol5:166-181, 1962.
4.
4. Sodi-Pallares D, et al: Effects of an intravenous infusion of GIK solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol5:166-181, 1962.
5.
5. Malmberg K, Ryden L, Efendic S, et al: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study). J Am Coll Cardiol26:57-65, 1995.
6.
6. Fath-Orboubadi F, Beatt KJ: Glucose insulin potassium therapy for treatment of acute myocardial infarction. Circulation96:1152-1156, 1997.
7.
7. Diaz R, Paolasso FA, Piegas LS, et al: Metabolic modulation of acute myocardial infarction. Circulation98:2227-2234, 1998.
8.
8. Merhige ME, Ekas R, Mossberg K, et al: Catecholamine stimulation, substrate competition and myocardial glucose uptake in conscious dogs assessed with positron emission tomography. Circ Res61(suppl II):II-124-II-129, 1987.
9.
9. Swedjeholm R, Huljebrant I, Hakanson E, et al: Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations. Ann Thorac Surg59:S23-S30, 1995.
11. Taegtmeyer H, Goodwin GW, Doenst T, et al: Substrate metabolism as a determinant for posticschemic functional recovery of the heart. Am J Cardiol80:3A-10A, 1997.
12.
12. Lazar HL, Chipkin S, Philippides G, et al: Glucose insulin potassium solutions improve outcomes in diabetics who have coronary artery disease. Ann Thorac Surg70:145-150, 2000.
13.
13. Carson JL, Scholz PM, Chen AY, et al: Diabetes mellitus increases short term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol40:418-423, 2002.
14.
14. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med345:1359-1367, 2001.
15.
15. Pietersen HG, Langenberg CJ, Geskes G, et al: Myocardial substrate oxidation during and after routine cardiac surgery. J Thorac Cardiovasc Surg118:71-80, 1999.
16.
16. Chaney MA, Nikolov MP, Blakeman BP, et al: Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg89:1091-1095, 1999.
17.
17. Depre CH, Vanoverschelde JL, Taegtmeyer H, et al: Glucose for the heart. Circulation99:578-588, 1999.
18.
18. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes. A systematic overview. Lancet355:773-778, 2000.
19.
19. Norhammar AM, Ryden L, Malmberg K, et al: Admission plasma glucose: Independent risk factor for longterm prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care22:1827-1831, 1999.
20.
20. Malmberg K, Norhammar A, Wedel H, et al: Glucometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Circulation99:2626-2632, 1999.
21.
21. Zindrou D, Taylor KM, Bagger JP, et al: Admission plasma glucose: An independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care24:1634-1639, 2001.
22.
22. Davies MJ, Lawrence IG, et al: DIGAMI (Diabetes Mellitus, Insulin-Glucose Infusion in Acute Myocardial Infarction); theory and practice. Diabetes Obes Metab4:289-295, 2002.
23.
23. Opie LH: Cardiac metabolism-emergence, decline and resurgence. Part II. Cardiovasc Res26:817-826, 1992.
24.
24. Liu B, el Alaoui-Talibi Z, Clanachan AS, et al: Uncoupling of contractile function from mitochondrial TCA cycle activity and myocardial oxygen consumption during reperfusion of ischemic hearts. Am J Physiol270:H72-H80, 1996.
25.
25. Neeley JR, Morgan HE: Effects of ischemia on function and metabolism of the isolated working rat heart. Ann Rev Physiol36:413-459, 1974.
26.
26. Jonassen AK, Brar BK, Mjos OD, et al: Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol32:757-764, 2000.
27.
27. Gottlieb RA, Engler RL: Apoptosis in myocardial ischemiareperfusion. Ann NY Acad Sci874:412-426, 1999.
28.
28. Ausma J, Thone F, Dispersyn GD, et al: Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol Cell Biochem186:159-168, 1998.
29.
29. Van den Hof MJ, van den Einde SM, Virugh S, et al: Programmed cell death in the developing heart. Cardiovasc Res45:603-620, 2000.
30.
30. Aebert H, Cornelius T, Birnbaum DE, et al: Induction of early immediate genes and programmed cell death following cardioplegic arrest in human hearts. Eur J Cardiothorac Surg12:261-267, 1997.
31.
31. Meyer C, Swaiger M: Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol80:94A-1010A, 1997.
32.
32. Smith A, Grattan A, Harper M, et al: Coronary revascularization: A procedure in transition from on-pump to offpump? The role of GIK revisited in a randomized placebocontrolled study. J Cardiothorac Vasc Anes16:413-420, 2002.
33.
33. Groban L, Butterworth J, Legault C, et al: Intraoperative insulin therapy does not reduce the need for inotropic or antiarrhythmic therapy after cardiopulmonary bypass. J Cardiothorac Vasc Anesth16:405-412, 2002.
34.
34. Lell W, Nielsen VG, McGiffin DC, et al: GIK infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg73:1246-1252, 2002.
35.
35. Bruemmer-Smith S, Avidan MS, Harris B: Glucose insulin potassium for heart protection during cardiac surgery. Br J Anaesth88:489-495, 2002.
